Efficacy and Safety of Oral Budesonide in Patients
Efficacy and Safety of Oral Budesonide in Patients with Active Crohn's Disease in Japan: A Multicenter, Double-Blind, Randomized, Parallel-Group Phase 3 Study Inflamm Intest Dis - DOI: 10. 1159/000484047 © 2017 The Author(s) Published by S. Karger AG, Basel - CC BY-NC-ND 4. 0
Efficacy and Safety of Oral Budesonide in Patients with Active Crohn's Disease in Japan: A Multicenter, Double-Blind, Randomized, Parallel-Group Phase 3 Study Inflamm Intest Dis - DOI: 10. 1159/000484047 © 2017 The Author(s) Published by S. Karger AG, Basel - CC BY-NC-ND 4. 0
Efficacy and Safety of Oral Budesonide in Patients with Active Crohn's Disease in Japan: A Multicenter, Double-Blind, Randomized, Parallel-Group Phase 3 Study Inflamm Intest Dis - DOI: 10. 1159/000484047 © 2017 The Author(s) Published by S. Karger AG, Basel - CC BY-NC-ND 4. 0
Efficacy and Safety of Oral Budesonide in Patients with Active Crohn's Disease in Japan: A Multicenter, Double-Blind, Randomized, Parallel-Group Phase 3 Study Inflamm Intest Dis - DOI: 10. 1159/000484047 © 2017 The Author(s) Published by S. Karger AG, Basel - CC BY-NC-ND 4. 0
Efficacy and Safety of Oral Budesonide in Patients with Active Crohn's Disease in Japan: A Multicenter, Double-Blind, Randomized, Parallel-Group Phase 3 Study Inflamm Intest Dis - DOI: 10. 1159/000484047 © 2017 The Author(s) Published by S. Karger AG, Basel - CC BY-NC-ND 4. 0
Efficacy and Safety of Oral Budesonide in Patients with Active Crohn's Disease in Japan: A Multicenter, Double-Blind, Randomized, Parallel-Group Phase 3 Study Inflamm Intest Dis - DOI: 10. 1159/000484047 © 2017 The Author(s) Published by S. Karger AG, Basel - CC BY-NC-ND 4. 0
- Slides: 6